These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659 [TBL] [Abstract][Full Text] [Related]
5. Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection. Wieland A; Shashidharamurthy R; Kamphorst AO; Han JH; Aubert RD; Choudhury BP; Stowell SR; Lee J; Punkosdy GA; Shlomchik MJ; Selvaraj P; Ahmed R Immunity; 2015 Feb; 42(2):367-378. PubMed ID: 25680276 [TBL] [Abstract][Full Text] [Related]
6. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement. Richter K; Oxenius A Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374 [TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes. Mothé BR; Stewart BS; Oseroff C; Bui HH; Stogiera S; Garcia Z; Dow C; Rodriguez-Carreno MP; Kotturi M; Pasquetto V; Botten J; Crotty S; Janssen E; Buchmeier MJ; Sette A J Immunol; 2007 Jul; 179(2):1058-67. PubMed ID: 17617598 [TBL] [Abstract][Full Text] [Related]
8. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Matloubian M; Concepcion RJ; Ahmed R J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595 [TBL] [Abstract][Full Text] [Related]
9. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468 [TBL] [Abstract][Full Text] [Related]
10. Analyzing Mouse B Cell Responses Specific to LCMV Infection. Hao Y; Li Z; Wang Y; Liu X; Ye L Methods Mol Biol; 2018; 1707():15-38. PubMed ID: 29388097 [TBL] [Abstract][Full Text] [Related]
11. IL-12 is not required for induction of type 1 cytokine responses in viral infections. Oxenius A; Karrer U; Zinkernagel RM; Hengartner H J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721 [TBL] [Abstract][Full Text] [Related]
12. B cell-derived IL-27 promotes control of persistent LCMV infection. Pratumchai I; Zak J; Huang Z; Min B; Oldstone MBA; Teijaro JR Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35022243 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13. Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118 [TBL] [Abstract][Full Text] [Related]
14. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes. Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957 [TBL] [Abstract][Full Text] [Related]
15. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. Nahill SR; Welsh RM J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891 [TBL] [Abstract][Full Text] [Related]
16. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR. Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925 [TBL] [Abstract][Full Text] [Related]
18. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. Yamada DH; Elsaesser H; Lux A; Timmerman JM; Morrison SL; de la Torre JC; Nimmerjahn F; Brooks DG Immunity; 2015 Feb; 42(2):379-390. PubMed ID: 25680277 [TBL] [Abstract][Full Text] [Related]
19. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection. Suresh M; Gao X; Fischer C; Miller NE; Tewari K J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807 [TBL] [Abstract][Full Text] [Related]
20. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen. Jellison ER; Guay HM; Szomolanyi-Tsuda E; Welsh RM Eur J Immunol; 2007 Jan; 37(1):119-28. PubMed ID: 17163452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]